Merck Failed To Probe Diabetes Drugs For Risks: FDA
The U.S. Food and Drug Administration warned Merck & Co. Inc. that it faces possible fines for missing a deadline by more than a year to probe pancreatitis risks tied to...To view the full article, register now.
Already a subscriber? Click here to view full article